Mirum Pharmaceuticals, Inc. Contracts & Agreements

62 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Mirum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Mirum Pharmaceuticals, Inc.
2024
Forms of restricted stock unit grant notice and award agreement for non-employee directors electing to defer settlement of restructured stock units under the Mirum...
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2024
Offer Letter by and between the Registrant and Joanne Quan, dated January 11, 2024
Mirum Pharmaceuticals, Inc.
2024
Description of Common Stock of the Registrant
Stock Agreements
Mirum Pharmaceuticals, Inc.
2024
Mirum Pharmaceuticals, Inc. 2020 Inducement plan, as amended August 24, 2023
Mirum Pharmaceuticals, Inc.
2024
Office Lease, dated January 17, 2024, by and between the Registrant and Hudson Metro Center, LLC
Lease Agreements
Mirum Pharmaceuticals, Inc.
2024
Mirum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Mirum Pharmaceuticals, Inc.
2024
Third Amendment to Office Lease, dated January 17, 2024, by and between the Registrant and Hudson Metro Center, LLC
Lease Agreements
Mirum Pharmaceuticals, Inc.
2024
Sales Agreement by and between the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co., dated November 2, 2023
Sales Agreements
Mirum Pharmaceuticals, Inc.
2023
Offer Letter by and between the Company and Eric Bjerkholt, dated August 8, 2023
Mirum Pharmaceuticals, Inc.
2023
Mirum Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan and form of Participation Agreement thereunder
Severance Agreements
Mirum Pharmaceuticals, Inc.
2023
Form of Subscription Agreement
Subscription Agreements
Mirum Pharmaceuticals, Inc.
2023
Asset Purchase Agreement, dated July 16, 2023, by and between Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc
Purchase Agreements
Mirum Pharmaceuticals, Inc.
2023
Form of Subscription Agreement
Subscription Agreements
Mirum Pharmaceuticals, Inc.
2023
Form of Registration Rights Agreement
Registration Rights Agreements
Mirum Pharmaceuticals, Inc.
2023
Indenture, dated as of April 17, 2023, between Mirum Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
DE
2023
Transition, Separation and Consulting Agreement, dated January 7, 2023, by and between the Registrant and Ian Clements, Ph.D
Consulting Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2023
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, SVB Securities LLC and Evercore Group L.L.C., dated August 9, 2022
Underwriting Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
NY
2022
Forms of international grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2022
Forms of international director grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2022
Forms of international restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2022
Mirum Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan Terms and conditions Non-U.S. Participants
Stock Agreements
Mirum Pharmaceuticals, Inc.
2022
Forms of international grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan
Stock Agreements
Mirum Pharmaceuticals, Inc.
2022
Forms of international restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan
Stock Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
DE
2022
Mirum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended March 18, 2020
Compensation Agreements
Mirum Pharmaceuticals, Inc.
2022
Asset Purchase Agreement, dated November 16, 2021, by and between the Registrant and Janssen Biotech, Inc
Purchase Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
DE
2021
Amendment No. 1 to Revenue Interest Purchase Agreement, dated September 28, 2021
Purchase Agreements
Mirum Pharmaceuticals, Inc.
2021
Offer Letter by and between the Registrant and Peter Radovich, dated April 28, 2020
Mirum Pharmaceuticals, Inc.
Biotechnology
2021
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC and Evercore Group L.L.C., dated December 14, 2020
Underwriting Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
NY
2020
Mirum Pharmaceuticals, Inc. 2020 Inducement Plan
Mirum Pharmaceuticals, Inc.
2020
Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan
Stock Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2020
Forms of restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2020 Inducement Plan
Stock Agreements
Mirum Pharmaceuticals, Inc.
2020
Description of Common Stock of the Registrant
Stock Agreements
Mirum Pharmaceuticals, Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Mirum Pharmaceuticals, Inc.
2020
Office Lease by and between the Registrant and Hudson Metro Center, LLC, dated January 22, 2019, as amended by First Amendment by and between the Registrant and Hudson Metro...
Lease Agreements
Mirum Pharmaceuticals, Inc.
2020
Amended and Restated Offer Letter by and between the Company and Michael Grey, dated May 15, 2019, as amended by the Letter Agreement by and between the Company and Michael Grey,...
Mirum Pharmaceuticals, Inc.
2019
Offer Letter by and between the Registrant and Edwin J. Tucker, MD, dated October 21, 2019
Mirum Pharmaceuticals, Inc.
2019
Form of Underwriting Agreement
Underwriting Agreements
Mirum Pharmaceuticals, Inc.
2019
Form of Common Stock Certificate
Stock Agreements
Mirum Pharmaceuticals, Inc.
2019
Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, to be in effect when this registration statement is declared effective
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2019
Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, to be in effect when this registration...
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Forms of restricted stock unit grant notice and award agreement under the Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, to be in effect when this registration statement...
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2019
Mirum Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Form of Indemnification Agreement by and between the Registrant and each director and executive officer
Indemnification Agreements
Mirum Pharmaceuticals, Inc.
2019
License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012
License Agreements
Mirum Pharmaceuticals, Inc.
2019
Investors Rights Agreement, dated November 5, 2018
Investor Rights Agreements
Mirum Pharmaceuticals, Inc.
2019
Mirum Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
2019
Forms of grant notice, stock option agreement and notice of exercise under the Mirum Pharmaceuticals, Inc. 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
CA
2019
Mirum Pharmaceuticals, Inc. Severance Benefit Plan and form of Participation Agreement thereunder
Severance Agreements
Mirum Pharmaceuticals, Inc.
2019
Amended and Restated Offer Letter by and between the Registrant and Michael Grey, dated May 15, 2019
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Amended and Restated Offer Letter by and between the Registrant and Christopher Peetz, dated May 15, 2019
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Offer Letter by and between the Registrant and Pamela Vig, Ph.D., dated December 1, 2018
Mirum Pharmaceuticals, Inc.
2019
Offer Letter by and between the Registrant and Lara Longpre, dated December 1, 2018
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Offer Letter by and between the Registrant and Ian Clements, Ph.D., dated March 4, 2019
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
Office Lease by and between the Registrant and Hudson Metro Center, LLC, dated January 22, 2019
Lease Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
CA
2019
License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 8, 2011
License Agreements
Mirum Pharmaceuticals, Inc.
2019
Amendment to License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 28, 2011
License Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
2019
License Agreement by and between Lumena Pharmaceuticals, Inc. and Pfizer Inc., dated June 1, 2012
License Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
DE
2019
Amendment No. 1 to License Agreement by and between Shire Orphan and Rare Disease GmbH (successor in interest of Lumena Pharmaceuticals, Inc.) and Sanofi-Aventis Deutschland GmbH,...
License Agreements
Mirum Pharmaceuticals, Inc.
2019
Assignment and License Agreement by and between the Registrant and Shire International GmbH, dated November 5, 2018
License Agreements
Mirum Pharmaceuticals, Inc.
2019
Transition Services Agreement by and between the Registrant and Shire International GmbH, dated January 28, 2019
Transition Agreements
Mirum Pharmaceuticals, Inc.
2019
License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012
License Agreements
Mirum Pharmaceuticals, Inc.
2019